ACCESSION: MSBNK-SMB_Measured-HSA015P0100016
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 37
COMMENT: RAW_SPEC {'EL23_pos_10306': {'bp': 52963.0, 'sum': 253256.0}, 'EL20_pos_10426': {'bp': 44229.0, 'sum': 234183.0}, 'EL13_pos_10414': {'bp': 45677.0, 'sum': 232353.0}, 'EL11_pos_10252': {'bp': 46678.0, 'sum': 252569.0}, 'EL17_pos_10469': {'bp': 47946.0, 'sum': 267739.0}, 'EL15_pos_10444': {'bp': 48385.0, 'sum': 257137.0}, 'EL24_pos_10402': {'bp': 37304.0, 'sum': 213110.0}, 'Blanc2-pos_9352': {'bp': 42771.0, 'sum': 231982.0}, 'EL20_pos_10300': {'bp': 46511.0, 'sum': 228142.0}, 'EL01_pos_10475': {'bp': 45543.0, 'sum': 228680.0}, 'EL07_pos_10268': {'bp': 43988.0, 'sum': 229779.0}, 'EL04_pos_10421': {'bp': 43886.0, 'sum': 242969.0}, 'EL07_pos_10450': {'bp': 41892.0, 'sum': 249340.0}, 'Blanc2-pos_10203': {'bp': 26665.0, 'sum': 189817.0}, 'EL18_pos_10295': {'bp': 45981.0, 'sum': 230292.0}, 'EL10_pos_10253': {'bp': 40345.0, 'sum': 222739.0}, 'EL10_pos_10504': {'bp': 35052.0, 'sum': 224016.0}, 'EL24_pos_10547': {'bp': 33910.0, 'sum': 207161.0}, 'EL23_pos_10439': {'bp': 43396.0, 'sum': 229919.0}, 'EL08_pos_10409': {'bp': 42595.0, 'sum': 250921.0}, 'EL23_pos_10367': {'bp': 50346.0, 'sum': 230832.0}, 'EL01_pos_10282': {'bp': 43465.0, 'sum': 248086.0}, 'EL16_pos_10408': {'bp': 41169.0, 'sum': 210523.0}, 'EL18_pos_10451': {'bp': 39052.0, 'sum': 218685.0}, 'EL01_pos_10600': {'bp': 36979.0, 'sum': 269270.0}, 'EL14_pos_10319': {'bp': 48690.0, 'sum': 250977.0}, 'EL04_pos_10481': {'bp': 42296.0, 'sum': 216189.0}, 'EL24_pos_10277': {'bp': 42102.0, 'sum': 233799.0}, 'EL18_pos_10511': {'bp': 41594.0, 'sum': 235595.0}, 'EL14_pos_10517': {'bp': 40761.0, 'sum': 227471.0}, 'EL14_pos_10455': {'bp': 39857.0, 'sum': 231796.0}, 'EL14_pos_10378': {'bp': 49880.0, 'sum': 239879.0}, 'EL04_pos_10282': {'bp': 44647.0, 'sum': 222960.0}, 'EL09_pos_10546': {'bp': 34614.0, 'sum': 210472.0}, 'EL11_pos_10467': {'bp': 42541.0, 'sum': 231294.0}, 'EL18_pos_10025': {'bp': 46573.0, 'sum': 265133.0}, 'EL16_pos_10527': {'bp': 35755.0, 'sum': 225590.0}}
COMMENT: RETENTION_TIME_STDEV 0.320
COMMENT: PRECURSOR_M/Z_RAW 100.112625
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 mz 100.112111; int 36.110; delta(ppm) 0.970373
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.313; C6H13N; [M+H]+; delta(ppm) 0.312800
COMMENT: PROPOSED_MF MS-FINDER 3.530; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.276; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H13N; [M+H]+; delta(ppm) 0.301123
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.197; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; CC1CCCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.028; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; NC1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.977; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; N1CCC(C)CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.917; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; CN1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.867; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; CCN1CCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.082; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethylmethacrylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.040; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; Cyclohexylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.873; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-penten-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.738; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.582; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.571; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; 2-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.561; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.526; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethylmethacrylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-penten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.672; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; NNWUEBIEOFQMSS-UHFFFAOYNA-N; [M+H]+; 2-Methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.637; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; Cyclohexylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.328; PAFZNILMFXTMIY-UHFFFAOYSA-N; [M+H]+; cyclohexanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.037; ZSIQJIWKELUFRJ-UHFFFAOYSA-N; [M+H]+; azepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.022; PAMIQIKDUOTOBW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.437; NNWUEBIEOFQMSS-UHFFFAOYSA-N; [M+H]+; 2-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.339; AXTLFVLHXSDZOW-UHFFFAOYSA-N; [M+H]+; N-ethyl-2-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.223; GKZOJSZSGYEWSA-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.166; UZOFELREXGAFOI-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.164; PBEJOEYAKXHDJT-UHFFFAOYSA-N; [M+H]+; hex-5-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; UHFLNWZBNRVHGM-UHFFFAOYSA-N; [M+H]+; N-(cyclopropylmethyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; JPWYYRCELICUKE-UHFFFAOYSA-N; [M+H]+; N-ethylcyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.112; IHSJXWLJYTXOCL-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; FICBXRYQMBKLJJ-UHFFFAOYSA-N; [M+H]+; hex-5-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; MGAPESYORZVKQD-UHFFFAOYSA-N; [M+H]+; 2-cyclobutylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; DFDDLFCSYLTQBP-UHFFFAOYSA-N; [M+H]+; 1-cyclobutyl-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; FESRYVBBESMTNR-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; SQULHOYRZBAPJF-UHFFFAOYSA-N; [M+H]+; N-methylpent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; GDGHPMLCHFTAIY-UHFFFAOYSA-N; [M+H]+; 1-cyclobutylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; ULELCQYQCBHXFY-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; KGNHJDRDIDXUHY-UHFFFAOYSA-N; [M+H]+; 4-methylpent-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; WFJUBRAHXQCZAM-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; VMVQWPJUETYXCM-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(2-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; DOAMTLHAIDSDBV-UHFFFAOYSA-N; [M+H]+; 1-(1-methylcyclopropyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; AZJUGPLDDAZZTB-NSCUHMNNSA-N; [M+H]+; (E)-hex-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; QTLHJKSNSNAIIC-UHFFFAOYSA-N; [M+H]+; 2-(1-methylcyclopropyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; DHOZGVQOZATZGP-UHFFFAOYSA-N; [M+H]+; 3-methylpent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; JEGMWWXJUXDNJN-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; ONQBOTKLCMXPOF-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; TYDMZADCGUWTCH-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; LGSSDLSVHUCRFI-UHFFFAOYSA-N; [M+H]+; 3-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; OXXSMQHKMPTBAR-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; BRRVPUKFALTISS-UHFFFAOYSA-N; [M+H]+; N,1-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; RDOBCMAOFYDWKB-UHFFFAOYSA-N; [M+H]+; 3-ethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; DFEBPTMNVUHJRX-UHFFFAOYSA-N; [M+H]+; (1-ethylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; XGXNQIUNHHNDAQ-UHFFFAOYSA-N; [M+H]+; 1-ethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; CBWBPZZRBSZHEE-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.811; ZADCUMFVTUWSAW-UHFFFAOYSA-N; [M+H]+; 1-propylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; PYIHBODUNRRGKT-UHFFFAOYSA-N; [M+H]+; 1-ethyl-N-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; XNPZNZSQFBQSTE-PHDIDXHHSA-N; [M+H]+; (1R,2R)-2-propylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.804; ZEBFPAXSQXIPNF-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; FPMPHZAUZKHZNK-UHFFFAOYSA-N; [M+H]+; (2,2-dimethylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; NZBCGJVYSMLKRN-UHFFFAOYSA-N; [M+H]+; (1-methylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; GSVPWASAUVYUBM-UHFFFAOYSA-N; [M+H]+; (3-methylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; IAYACHHAXQZZTQ-PHDIDXHHSA-N; [M+H]+; [(1S,2R)-2-methylcyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; JFZLDRUSMYBXRI-UHFFFAOYSA-N; [M+H]+; 2-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; PHODFIDDEBEGCS-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.776; XBQNZPDIRJPFAI-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; KKTBUCVHSCATGB-UHFFFAOYSA-N; [M+H]+; N-methylcyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.773; UBLYEVLMRSPMOG-UHFFFAOYSA-N; [M+H]+; cyclopentylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; DZFFQSFNUBWNSF-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; DUOJVRWFIHNZTJ-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; ZKCLHJUZGZWTNA-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; ATTVJWQVBUVDOP-UHFFFAOYSA-N; [M+H]+; 2,2,4-trimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; IGQKKHDDJXCEFL-UHFFFAOYSA-N; [M+H]+; 2-methylpent-4-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; MDVHHYGTBKHJAU-UHFFFAOYSA-N; [M+H]+; 2-propan-2-ylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; OGZXOVGUHFDHOO-UHFFFAOYSA-N; [M+H]+; 2-propylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; TWASBYPJZBHZQJ-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.751; RDEHRKLSYJBKDV-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; VODADKFVZJNXGJ-UHFFFAOYSA-N; [M+H]+; 3-propan-2-ylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; ZZIYOZFERMXGHB-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; MMWAHLXGFZBYQU-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; JCGWCOCQLMXRKE-UHFFFAOYSA-N; [M+H]+; 3-ethyl-3-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; JSLNMYHDORBKGU-UHFFFAOYSA-N; [M+H]+; 1,2,2-trimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; ZWMRWMKTTMIHRM-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; PAKOTDFUHRYXRU-NTSWFWBYSA-N; [M+H]+; (1R,2S)-2-propan-2-ylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.687; OOXIEUXBOSSXJM-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.684; BCEQMDPSJGINGM-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.683; HNIFLEDIIDJDLD-UHFFFAOYSA-N; [M+H]+; 2,2,3-trimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.115; HUEPADWXXGLLSW-UHFFFAOYSA-N; [M+H]+; N-prop-2-enylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.114; XWGXFOVSOYMSGT-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; DAOWJXCNVJBLNI-UHFFFAOYSA-N; [M+H]+; N-propylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; UCJOAMOXKLJGST-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylpropan-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; OWUBKHTYXCOYMM-UHFFFAOYSA-N; [M+H]+; N-prop-2-enylpropan-2-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H14N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.924
MS$FOCUSED_ION: PRECURSOR_M/Z 100.112106
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0zfs-9400000000-a174a2f7375a46048f33
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545322 660.8886 55.055240 0.4359 86.18 0.4793 37 f{C4H7}/5.55ppm,p-C2H7N1
  56.0497035 101.6081 56.050416 1.0170 30.32 -0.1574 28 f{C3H6N1}/4.07ppm,p-C3H8
  56.9650040 99.5878 56.965720 1.1586 91.62 0.4128 32 ?
  57.0449836 70.8640 57.045700 1.2622 22.19 -0.3700 31 ?
  58.0653397 96.6033 58.066060 1.0505 20.23 0.1089 32 f{C3H8N1}/3.69ppm,p-C3H6
  59.0606162 225.1102 59.061340 1.0159 103.11 -0.3353 35 ?
  72.0809171 105.2173 72.081660 1.1515 27.30 0.3544 34 f{C4H10N1}/1.96ppm,p-C2H4
  74.0965487 107.3559 74.097290 1.2416 25.15 0.3232 34 f{C4H12N1}/1.66ppm,p-C2H2
  83.0856106 516.5651 83.086330 0.5416 59.91 0.3389 37 f{C6H11}/1.01ppm,p-H3N1
  98.0600476 89.8767 98.060677 1.4583 22.27 0.2955 30 ?
  98.9842086 999.0000 98.984830 0.3940 7.40 0.5481 37 ?
  99.0552892 80.9683 99.055910 1.3225 23.13 -0.2113 26 ?
  100.0757281 772.7502 100.076340 0.4397 106.59 -0.0750 37 ?
  100.1121085 254.4995 100.112720 1.1287 62.60 1.0000 33 f{C6H14N1}/0.33ppm,p
  102.1277670 436.4742 102.128360 0.6952 87.86 0.3653 37 ?
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  55.054532 660.89 660
  56.049703 101.61 101
  56.965004 99.59 99
  57.044984 70.86 70
  58.065340 96.60 96
  59.060616 225.11 225
  72.080917 105.22 105
  74.096549 107.36 107
  83.085611 516.57 516
  98.060048 89.88 89
  98.984209 999.00 999
  99.055289 80.97 80
  100.075728 772.75 772
  100.112108 254.50 254
  102.127767 436.47 436
//
